Extracts from fruits of saw palmetto (Sabal serrulata) and roots of stinging nettle (Urtica dioica):: Viable alternatives in the medical treatment of benign prostatic hyperplasia and associated lower urinary tracts symptoms

被引:65
作者
Koch, E [1 ]
机构
[1] Dr Willmar Schwabe Arzneimittel GmbH, Dept Pharmacol, D-76227 Karlsruhe, Germany
关键词
benign prostatic hyperplasia; lower urinary tract symptoms; phytopharmaceuticals; pharmacology; clinic; Sabal serrulata; Serenoa repens; Urtica dioica; saw palmetto; stinging nettle;
D O I
10.1055/s-2001-16496
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Benign prostatic hyperplasia (BPH) and associated lower urinary tract symptoms (LUTS) are very common disorders in aging men. Despite the great clinical importance, many aspects of their aetiology remain uncertain although it is generally accepted that advanced age and testicular androgens are important requirements for the development of these complaints. The currently available therapeutic options include watchful waiting, changes of life style, medical treatments and invasive therapies. In many European countries the use of phytopharmaceuticals for the management of BPH and related LUTS is common and these products represent up to 80% of all drugs prescribed for this disorder. In particularly, extracts from the fruits of saw palmetto (Sabal serrulata, syn. Serenoa repens) and the roots of stinging nettle (Urtica dioica) are popular. During the last years numerous papers have been published which elaborated on the pharmacological activities and the clinical assessment of these herbal remedies. These investigations have not only broadened the scientific basis for the rational use of phytotherapeutics but have also provided evidence for their therapeutic efficacy and favourable safety profile.
引用
收藏
页码:489 / 500
页数:12
相关论文
共 114 条
[11]  
BREU W, 1992, Z PHYTOTHERAPIE, V13, P107
[12]   Phytotherapy for the prostate [J].
Buck, AC .
BRITISH JOURNAL OF UROLOGY, 1996, 78 (03) :325-336
[13]   BINDING OF PERMIXON, A NEW TREATMENT FOR PROSTATIC BENIGN HYPERPLASIA, TO THE CYTOSOLIC ANDROGEN RECEPTOR IN THE RAT PROSTATE [J].
CARILLA, E ;
BRILEY, M ;
FAURAN, F ;
SULTAN, C ;
DUVILLIERS, C .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1984, 20 (01) :521-523
[14]  
CASAROSA C, 1988, CLIN THER, V10, P585
[15]  
Chang WY, 1999, PROSTATE, V40, P115
[16]   Distribution study of radioactivity in rats after oral administration of the lipido/sterolic extract of Serenoa repens (Permixon(R)) supplemented with [1-C-14]-lauric acid, [1-C-14]-oleic acid or [4-C-14]-beta-sitosterol [J].
Chevalier, G ;
Benard, P ;
Cousse, H ;
Bengone, T .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1997, 22 (01) :73-83
[17]   TISSUE INTERACTIONS AND PROSTATIC GROWTH - A NEW MOUSE MODEL FOR PROSTATIC HYPERPLASIA [J].
CHUNG, LWK ;
MATSUURA, J ;
ROCCO, AK ;
THOMPSON, TC ;
MILLER, GJ ;
RUNNER, MN .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1984, 438 (DEC) :394-404
[18]  
Culig Z, 1996, PROSTATE, V28, P392, DOI 10.1002/(SICI)1097-0045(199606)28:6<392::AID-PROS9>3.0.CO
[19]  
2-C
[20]  
DAUBE G, 1988, BENIGNE PROSTATAHYPE, V2, P63